PATH and United Kingdom-based test developer Mologic have entered an agreement to advance a new rapid diagnostic test to support treatment and elimination of Plasmodium vivax, or relapsing, malaria.

Say you’re a health ministry staffer for a small country in the developing world or a health department leader in a tiny American county. Your boss has just assigned you to evaluate the more than ...

Iron Path Capital has made an investment in Versant Diagnostics, a physician services company focused on anatomic pathology. No financial terms were disclosed. Ziegler was financial advisor to Versant ...

The Tucson-based Critical Path Institute is working to create a standard-setting body to evaluate the performance of diagnostic medical tests before their submission to the U.S. Food and Drug ...

CHICAGO--(BUSINESS WIRE)--Shore Capital Partners (“Shore Capital”), a healthcare-focused private equity firm, today announced the sale of ClearPath Diagnostics (“ClearPath”), a leading provider of ...

Last summer, the Food & Drug Administration published its final guidance on the development and approval path for companion diagnostics. These in vitro tests and devices put personalized medicine into ...